Test Price
950 AED✅ Home Collection Available
Immunohistochemistry Bladder vs Prostate Carcinoma Panel in UAE – 950 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Comprehensive IHC Panel for Differential Diagnosis of Bladder vs Prostate Carcinoma
This advanced immunohistochemistry panel precisely distinguishes primary bladder carcinoma from prostate carcinoma metastases using validated antibodies (e.g., CK7, CK20, PSA). The test is performed on formalin-fixed paraffin-embedded (FFPE) tissue blocks or biopsy slides, providing definitive classification to guide targeted therapy.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative (Standard IHC) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity, dual‑antibody panel with confirmatory molecular profiling when indicated | Variable (80–90% sensitivity), single‑marker approach |
| Methodology | Immunohistochemistry (IHC) with qualitative assessment plus LC-MS/MS backup for equivocal cases | Manual IHC without molecular confirmation |
| Turnaround Time | 5–7 working days (standard block: 5 days, complex tissue: 7 days) – samples accepted until 6 PM daily | 10–14 days with limited sample acceptance window |
| Logistics | Secure Medical Courier Solid Tissue Specimen Retrieval with cold-chain protocol | Clinic drop‑off only with ambient transport |
| Regulatory Compliance | DHA-regulated, ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139), UAE PDPL 2021 compliant | Unclear or incomplete regulatory adherence |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor (DHA Registration ID: 61713011, Specialist Diagnostic Radiology): “As a specialist in diagnostic imaging and tissue pathology, I want to emphasize that this IHC panel is a cornerstone for accurate tumor origin classification. The dual-antibody approach significantly reduces diagnostic ambiguity when distinguishing bladder from prostate primary sites. Clinicians should always correlate these results with full histopathological assessment and imaging findings. A negative result does not exclude malignancy; equivocal cases may require additional molecular testing or re-biopsy. Our laboratory follows stringent protocols to ensure every report is clinically actionable.”
Advisory Note on Specimen Handling
Critical Pre-Test Requirements
Archival Tissue Specimen – This test requires formalin-fixed paraffin-embedded (FFPE) tissue blocks, biopsy slides, or surgical pathology cuts. Patients must provide prior histopathology reports and complete clinical history. Secure Medical Courier Solid Tissue Specimen Retrieval is arranged through our logistics team. Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Exclusion Criteria & Safety Alerts
Red Flag Warnings
- Exclusion Criteria: Specimen volume insufficient for reliable staining; inability to provide prior histopathology report, biopsy site details, and clinical history. Patients with contraindications to tissue biopsy procedures must not undergo collection.
- Emergency Red Flags: Acute urinary retention, severe persistent hematuria, new‑onset bone pain, or sudden neurological symptoms require immediate emergency care – do not wait for test results.
Patient FAQ & Clinical Guidance
1. What does the bladder vs prostate IHC panel detect?
Snippet: This IHC panel identifies specific protein markers (CK7, CK20, p63, PSA) to differentiate bladder carcinoma from prostate carcinoma tissue origin.
The test uses validated antibodies targeting lineage-specific proteins to accurately classify metastatic tumor origin. A typical report indicates the immunoprofile (e.g., CK7+/CK20+ favours bladder primary; PSA+ indicates prostate origin) and helps your oncologist select the most effective therapy. It is performed on archival FFPE tissue, so no special preparation is needed beyond providing the original histopathology report and biopsy details.
2. How long does it take and how are specimens collected?
Snippet: Tissue block results are delivered within 5 working days; complex specimens require up to 7 days.
Final reports are available in 5–7 working days depending on specimen complexity (standard FFPE block: 5 days, large or complex tissue: 7 days). We offer Secure Medical Courier Solid Tissue Specimen Retrieval across the UAE – our trained logistics team ensures strict cold-chain transport of your archival tissue. Specimens are accepted daily until 6 PM; schedule collection via WhatsApp at +971545488731.
3. Will my insurance cover this test in Dubai and Abu Dhabi?
Snippet: Our team verifies direct billing eligibility with all major UAE insurers via WhatsApp within minutes.
We collaborate with leading insurers and comply with UAE DHA regulations. Before your collection, we confirm coverage and handle pre‑approval – simply send your insurance card photo via WhatsApp to +971545488731. The panel is priced at 950 AED, and any co‑payment is communicated transparently. All procedures adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Security: All patient data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is DHA-licensed (Facility License Number: 1143) and ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry Bladder vs Prostate Carcinoma Panel |
| Price (AED) | 950 |
| Turnaround Time | 5–7 Working Days |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block, Biopsy Slides, Surgical Pathology Cuts |
| Methodology Used | Immunohistochemistry (IHC) with qualitative assessment, confirmatory LC-MS/MS when indicated |
| ICD-10-CM Code | C67.9, C61 |
| LOINC Code | 102679-8 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians